New drug SSS67: first safety test in healthy volunteers begins
NCT ID NCT07487545
First seen Apr 05, 2026 · Last updated May 24, 2026 · Updated 5 times
Summary
This early-stage study tests a single dose of a new drug, SSS67, in 52 healthy adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo by IV, and researchers monitor side effects, drug levels, and immune responses. No treatment for any disease is being tested here—this is purely a safety and tolerability check.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Novatrials
Charlestown, New South Wales, 2290, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.